Overview

Penumbra, Inc., headquartered in Alameda, California, is a global healthcare company focused on interventional therapies. Penumbra designs, develops, manufactures and markets innovative devices and has a broad portfolio of products that addresses challenging medical conditions and significant clinical needs across two major markets, neuro and peripheral vascular. Penumbra sells its products to hospitals primarily through its direct sales organization in the United States, most of Europe, Canada and Australia, and through distributors in select international markets. The Penumbra logo is a trademark of Penumbra, Inc.

NYSE: PEN 95.55 +0.35 +0.37%
Volume: 85,309
Pricing delayed 20 minutes October 20, 2017 04:00 PM

SEC Filings

Date Filing Type Filing Description Download
Date October 10, 2017 Filing Type Form 4 Filing Description Statement of Changes in Beneficial Ownership Download
Date October 4, 2017 Filing Type Form 4 Filing Description Statement of Changes in Beneficial Ownership Download
Date September 29, 2017 Filing Type Form 4 Filing Description Statement of Changes in Beneficial Ownership Download

IR Contact

investors@penumbrainc.com

Penumbra, Inc. Headquarters One Penumbra Place
Alameda, CA 94502
USA